reference/3023548

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3023548

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't\|Research Support, U.S. Gov't, P.H.S.
endingPage	150
issn	0002-953X 1535-7228
issueIdentifier	1
pageRange	146-150
publicationName	The American journal of psychiatry
startingPage	146
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_cd23225bb8277d80089ba14432de98d3
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_4bbb53b150d9bea701f675f3ab6b83c1 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_a22e16ec482e5e0c360976183368015f http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_0a281f099b9912bac189d52035685479
bibliographicCitation	Lenze EJ, Mulsant BH, Shear MK, Dew MA, Miller MD, Pollock BG, Houck P, Tracey B, Reynolds CF. Efficacy and tolerability of citalopram in the treatment of late-life anxiety disorders: results from an 8-week randomized, placebo-controlled trial. Am J Psychiatry. 2005 Jan;162(1):146–50. doi: 10.1176/appi.ajp.162.1.146. PMID: 15625213.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_da08c8b0b7d907427eae78cb77b3e7ae http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_50852d49e3442560ed5aa9dab05ff569 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_17c9527c982b2fe874ab5b6c3d212c2f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b569bc3e38c6fc6c2901206a92109182 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_804537a81a5e8086f6a73de7b9e602c1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4cbe02ad9ec1ee6b15bbc7690934ba5b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d1c9f60f1ee933ee997d8f83e39ae5a2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8d2345c2f47aa79f5430444b818e7d50 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef1fe99c9f9b89072cddb80aefb093f4
date	200501
identifier	https://pubmed.ncbi.nlm.nih.gov/15625213 https://doi.org/10.1176/appi.ajp.162.1.146
isPartOf	https://portal.issn.org/resource/ISSN/0002-953X https://portal.issn.org/resource/ISSN/1535-7228 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/457
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Efficacy and Tolerability of Citalopram in the Treatment of Late-Life Anxiety Disorders: Results From an 8-Week Randomized, Placebo-Controlled Trial
discusses	http://id.nlm.nih.gov/mesh/M0016932 http://id.nlm.nih.gov/mesh/M0026372 http://id.nlm.nih.gov/mesh/M0023529
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D017367Q000627 http://id.nlm.nih.gov/mesh/D001008Q000188 http://id.nlm.nih.gov/mesh/D015283Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D011446 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D017367Q000009 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D011569 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D001008Q000175 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D001008Q000523 http://id.nlm.nih.gov/mesh/D010919 http://id.nlm.nih.gov/mesh/D000367 http://id.nlm.nih.gov/mesh/D015283Q000009
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6923 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5202 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2771

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129095671 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129626560

Total number of triples: 57.